Goldman Sachs Group Inc Chroma Dex Corp. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 171,080 shares of CDXC stock, worth $927,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,080
Previous 145,027
17.96%
Holding current value
$927,253
Previous $529,000
71.64%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$18.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$16.9 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$14 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.03 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.26 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $370M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...